Product Information

LABETALOL HCL 100 MG TABLET is a generic product labeled by Biocon Pharma Inc., priced at $0.0843 per EA under NDC 70377006012. Its NADAC has been published 255 times since Aug 11, 2021.

The High Outlier badge above means this manufacturer's average price in the Labetalol Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LABETALOL HCL 100 MG TABLET

Labetalol Hydrochloride
$0.0843per EA
High Outlier

Strength

100 mg/1

Manufacturer

Biocon Pharma Inc.

NDC

70377006012

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

LABETALOL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA209603

On Market Since

5/27/2021

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price Statistics

The NADAC for LABETALOL HCL 100 MG TABLET has been published 255 times since Aug 11, 2021, and over the history we have for it it has declined 38.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0843 per EA
All-time high$0.1624 (Nov 10, 2021)
All-time low$0.0789 (Mar 18, 2026)
52-week high$0.0863
52-week low$0.0789
Median price$0.1085
Average price$0.1064
Largest weekly change+34.4% (Jun 19, 2024)
Weeks tracked255
Tracking sinceAug 11, 2021

Price History

1W

0.0%

1M

+4.4%

3M

+6.9%

6M

-0.0%

1Y

-2.3%

3Y

-13.0%

5Y

N/A

All

-38.4%

Generic Alternatives

The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LABETALOL HCL 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LABETALOL HCL 100 MG TABLET, manufactured by Biocon Pharma Inc., is $0.0843 per EA (NDC 70377006012), effective Jun 24, 2026.

How has the price of LABETALOL HCL 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for LABETALOL HCL 100 MG TABLET has declined 38.4%. It has been tracked across 255 weekly CMS publications since Aug 11, 2021.

What are the highest and lowest recorded NADAC prices for LABETALOL HCL 100 MG TABLET?

Since Aug 11, 2021, the NADAC for LABETALOL HCL 100 MG TABLET has ranged from a low of $0.0789 (Mar 18, 2026) to a high of $0.1624 (Nov 10, 2021), with a median of $0.1085 per EA.

Are there cheaper alternatives to LABETALOL HCL 100 MG TABLET?

Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LABETALOL HCL 100 MG TABLET, is $0.0807 per EA — about 4% below LABETALOL HCL 100 MG TABLET.

Who manufactures LABETALOL HCL 100 MG TABLET?

LABETALOL HCL 100 MG TABLET (NDC 70377006012) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.